{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:06:01Z","timestamp":1780099561553,"version":"3.54.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Novartis Pharma Research"},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP21ek0109543"],"award-info":[{"award-number":["JP21ek0109543"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["22K16147"],"award-info":[{"award-number":["22K16147"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The prognostic value of the presence of atrial fibrillation (AF) in patients at the time of cardiac sarcoidosis (CS) diagnosis is unknown. This study aimed to investigate the association between AF at the time of CS diagnosis and patient prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This study is a post-hoc analysis of Illustration of the Management and Prognosis of Japanese Patients with CS, a multicentre, retrospective observational study that evaluated the clinical characteristics and prognosis of patients with CS. The primary endpoint was the combined endpoint of all-cause death and hospitalization due to heart failure. After excluding patients with missing data about AF status, 445 patients (62 \u00b1 11 years, 36% males) diagnosed with CS according to the Japanese current diagnostic guideline were analysed. Compared to patients without AF, patients with AF (n = 46, 10%) had higher levels of brain natriuretic peptide and a higher prevalence of heart failure hospitalizations. During a median follow-up period of 3.2 years (interquartile range, 1.7\u20135.8 years), 80 primary endpoints were observed. Kaplan\u2013Meier curve analysis indicated that concomitant AF at the time of diagnosis was significantly associated with a high incidence of primary endpoints (log-rank P = 0.002). This association was retained after adjusting for known risk factors including log-transformed brain natriuretic peptide levels and left ventricular ejection fractions [hazard ratio, 1.96 (95% confidence interval, 1.05\u20133.65); P = 0.035].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The presence of AF at the time of CS diagnosis is associated with higher incidence of all-cause death and heart failure hospitalization.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjopen\/oead100","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:41:48Z","timestamp":1695732108000},"source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis"],"prefix":"10.1093","volume":"3","author":[{"given":"Yudai","family":"Fujimoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-8525","authenticated-orcid":false,"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Dotare","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Sunayama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iso","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Suresvar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Akama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kameda Medical Center , Kamogawa City , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center , Suita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-951X","authenticated-orcid":false,"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , Hamamatsu , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine , Suita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-7039","authenticated-orcid":false,"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine , Kobe , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-2052","authenticated-orcid":false,"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-0443","authenticated-orcid":false,"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University , Kochi , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-7667","authenticated-orcid":false,"given":"Takeru","family":"Nabeta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara , Japan"},{"name":"Department of Cardiology, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421 , Japan"},{"name":"Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"2023101616171751500_oead100-B1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis- digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"2023101616171751500_oead100-B2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"2023101616171751500_oead100-B3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2023101616171751500_oead100-B4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"2023101616171751500_oead100-B5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"2023101616171751500_oead100-B6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/eurheartj\/ehaa1078","article-title":"Incidence and outcome of atrial fibrillation: diversity throughout Europe","volume":"42","author":"Rienstra","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101616171751500_oead100-B7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hlc.2017.05.117","article-title":"Atrial fibrillation and heart failure\u2014cause or effect?","volume":"26","author":"Prabhu","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2023101616171751500_oead100-B8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2023101616171751500_oead100-B9","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101616171751500_oead100-B10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"2023101616171751500_oead100-B11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J Card Fail"},{"key":"2023101616171751500_oead100-B12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcmg.2020.08.037","article-title":"Multimodality imaging of atrial remodeling and risk of atrial fibrillation in patients with cardiac sarcoidosis","volume":"14","author":"Habibi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023101616171751500_oead100-B13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/HPC.0000000000000210","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: evidence-based review about mechanism, complications and management","volume":"19","author":"Arunachalam","year":"2020","journal-title":"Crit Pathw Cardiol"},{"key":"2023101616171751500_oead100-B14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2020.08.062","article-title":"Atrial fibrillation in dilated cardiomyopathy: outcome prediction from an observational registry","volume":"323","author":"Nuzzi","year":"2021","journal-title":"Int J Cardiol"},{"key":"2023101616171751500_oead100-B15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025803","article-title":"The prognostic value of B-type natriuretic peptide in patients with cardiac sarcoidosis without heart failure: insights from ILLUMINATE-CS","volume":"11","author":"Miyakuni","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2023101616171751500_oead100-B16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2023101616171751500_oead100-B17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2023101616171751500_oead100-B18","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.nuclcard.2006.08.009","article-title":"Positron emission tomography myocardial perfusion and glucose metabolism imaging","volume":"13","author":"Machac","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"2023101616171751500_oead100-B19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"key":"2023101616171751500_oead100-B20","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2023101616171751500_oead100-B21","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the heart failure collaboratory and Academic Research Consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023101616171751500_oead100-B22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2021.12.011","article-title":"Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy","volume":"246","author":"Higgins","year":"2022","journal-title":"Am Heart J"},{"key":"2023101616171751500_oead100-B23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCOUTCOMES.109.875658","article-title":"Missing data analysis using multiple imputation: getting to the heart of the matter","volume":"3","author":"He","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023101616171751500_oead100-B24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1536867X1101100305","article-title":"A closer examination of three small-sample approximations to the multiple-imputation degrees of freedom","volume":"11","author":"Wagstaff","year":"2011","journal-title":"Stata J"},{"key":"2023101616171751500_oead100-B25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023101616171751500_oead100-B26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2023101616171751500_oead100-B27","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1513\/AnnalsATS.201707-566OT","article-title":"High-risk sarcoidosis. current concepts and research imperatives","volume":"14","author":"Sauer","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2023101616171751500_oead100-B28","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jcmg.2022.02.025","article-title":"Incidence and predictors of atrial fibrillation in cardiac sarcoidosis: a multimodality imaging study","volume":"15","author":"Niemela","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023101616171751500_oead100-B29","first-page":"1288","article-title":"Atrial fibrillation in cardiac sarcoidosis","volume":"8","author":"Mehta","year":"2015","journal-title":"J Atr Fibrillation"},{"key":"2023101616171751500_oead100-B30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: A long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS One"},{"key":"2023101616171751500_oead100-B31","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"key":"2023101616171751500_oead100-B32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017086","article-title":"Atrial arrhythmias in clinically manifest cardiac sarcoidosis: incidence, burden, predictors, and outcomes","volume":"9","author":"Weng","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023101616171751500_oead100-B33","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.jacep.2021.09.006","article-title":"Association between sarcoidosis and atrial fibrillation among Californians using medical care","volume":"7","author":"Rosenthal","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2023101616171751500_oead100-B34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1253\/circj.71.308","article-title":"Development of congestive heart failure in Japanese patients with atrial fibrillation","volume":"71","author":"Fukuda","year":"2007","journal-title":"Circ J"},{"key":"2023101616171751500_oead100-B35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.je.2016.08.012","article-title":"Risk of stroke and heart failure attributable to atrial fibrillation in middle-aged and elderly people: results from a five-year prospective cohort study of Japanese community dwellers","volume":"27","author":"Ohsawa","year":"2017","journal-title":"J Epidemiol"},{"key":"2023101616171751500_oead100-B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2020.04.041","article-title":"Prevalence of atrial FDG uptake and association with atrial arrhythmias in patients with cardiac sarcoidosis","volume":"313","author":"Yodogawa","year":"2020","journal-title":"Int J Cardiol"},{"key":"2023101616171751500_oead100-B37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2023101616171751500_oead100-B38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","article-title":"Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality","volume":"57","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023101616171751500_oead100-B39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact","volume":"51","author":"Daubert","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023101616171751500_oead100-B40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J Leukoc Biol"},{"key":"2023101616171751500_oead100-B41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jce.12424","article-title":"Catheter ablation of atrial arrhythmias in cardiac sarcoidosis","volume":"25","author":"Willner","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023101616171751500_oead100-B42","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1136\/heartjnl-2022-320932","article-title":"Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis","volume":"108","author":"Kitai","year":"2022","journal-title":"Heart"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oead100\/51783050\/oead100.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/5\/oead100\/52173408\/oead100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/5\/oead100\/52173408\/oead100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T18:00:50Z","timestamp":1697479250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oead100\/7284307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oead100","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9]]},"article-number":"oead100"}}